학술논문

DOCOX: A phase II trial with docetaxel and oxaliplatin as a second-line systemic therapy for patients with advanced and/or metastatic adenocarcinoma of the pancreas
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2013, 31 15, 1p. Supplement: S
Subject
Language
English
ISSN
15277755